EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of ox‐LDL‐induced endothelial cell injury by LINC02381 knockdown through the microRNA‐491‐5p/transcription factor 7 axis

Xizheng Zhu, Hui Xu, Beijia Chen iD

Immunity, Inflammation and Disease · 2023

DOI: 10.1002/iid3.785 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2023. Verfasst von Xizheng Zhu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, Wuhan Asia General Hospital, Wuhan, China. Hauptthemen laut MEDLINE: Atherosclerosis, MicroRNAs, T Cell Transcription Factor 1, RNA, Long Noncoding. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis (AS) is a complex multifactorial and chronic inflammatory vascular disease that contributes to the development of cardiovascular diseases. Abnormal cellular proliferation in human umbilical vein endothelial cells (HUVECs) is a crucial element in AS development. In this study, we investigated the potential role of the long noncoding RNA LINC02381/microRNA (miR)‐491‐5p/transcription factor 7 (TCF7) axis in regulating HUVEC injury in 30 participants suffering from AS and 30 healthy control participants. We established an in vitro model of AS in HUVECs using oxidized low‐density lipoprotein (ox‐LDL), and measured cellular mRNA and protein levels of LINC02381, miR‐491‐5p, and TCF7 in serum samples using reverse transcription‐quantitative polymerase chain reaction and Western blotting assays. We evaluated cell viability, apoptosis, and inflammation using Cell Counting Kit‐8, flow cytometry, and enzyme‐linked immunosorbent assays, respectively. Moreover, we analyzed apoptosis‐related protein expression using western blotting analysis and determined the association between miR‐491‐5p and LINC02381 or TCF7 using dual‐luciferase reporter assay, RNA pull‐down, and rescue experiments. We observed that LINC02381 was elevated, while miR‐491‐5p was downregulated in serum samples from participants with AS and in ox‐LDL‐treated HUVECs. LINC02381 knockdown was protective against HUVEC injury via miR‐491‐5p inhibition, which is its downstream target. Rescue experiments further demonstrated that miR‐491‐5p alleviated HUVEC injury by modulating TCF7. Thus, LINC02381 knockdown ameliorated HUVEC injury by regulating the miR‐491‐5p/TCF7 axis, which provides new insights into AS treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisMicroRNAsT Cell Transcription Factor 1RNA, Long NoncodingHumansHuman Umbilical Vein Endothelial CellsLipoproteins, LDL

Stichwörter der Autor:innen

atherosclerosislncRNAlncRNA LINC02381miR-491-5pmiRNA

Substanzen

Lipoproteins, LDLMicroRNAsMIRN491 microRNA, humanoxidized low density lipoproteinT Cell Transcription Factor 1RNA, Long NoncodingTCF7 protein, human

Autor:innen und Institutionen

  • Department of Interventional Radiology, Wuhan Asia General Hospital, Wuhan, China.
  • Department of Cardiology, Fifth Hospital in Wuhan, Wuhan, China.

ORCID-Profile: Beijia Chen

Zitieren

APA

Zhu, X., Xu, H., & Chen, B. (2023). Inhibition of ox‐LDL‐induced endothelial cell injury by LINC02381 knockdown through the microRNA‐491‐5p/transcription factor 7 axis. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.785

Vancouver

Zhu X, Xu H, Chen B. Inhibition of ox‐LDL‐induced endothelial cell injury by LINC02381 knockdown through the microRNA‐491‐5p/transcription factor 7 axis. Immunity, Inflammation and Disease. 2023. doi:10.1002/iid3.785

BibTeX
@article{Zhu2023,
  author = {Zhu, Xizheng and Xu, Hui and Chen, Beijia},
  title = {Inhibition of ox‐LDL‐induced endothelial cell injury by LINC02381 knockdown through the microRNA‐491‐5p/transcription factor 7 axis},
  journal = {Immunity, Inflammation and Disease},
  year = {2023},
  doi = {10.1002/iid3.785}
}
Kostenlos starten →